Howard Horn's Net Worth
$12 Million
Who is Howard Horn?
Howard Horn has an estimated net worth of $12 Million. This is based on reported shares across multiple companies, which include Vir Biotechnology, Inc., and Ultragenyx Pharmaceutical Inc..
SEC CIK
Howard Horn's CIK is 0001786335
Past Insider Trading and Trends
2021 was Howard Horn's most active year for acquiring shares with 2 total transactions. Howard Horn's most active month to acquire stocks was the month of January. 2020 was Howard Horn's most active year for disposing of shares, totalling 9 transactions. Howard Horn's most active month to dispose stocks was the month of June. 2023 saw Howard Horn paying a total of $0.00 for 220,835 shares, this is the most they've acquired in one year. In 2020 Howard Horn cashed out on 100,000 shares for a total of $4,531,167.88, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Vir Biotechnology, Inc. (VIR) Snapshot price: $7.63
CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.96% | -2.25K |
$25.97 | -$58,387.30 | 230.71K |
Feb 23
| |||
Form 4
| -1.03% | -2.42K |
$25.29 | -$61,298.11 | 232.96K |
Feb 17
| |||
Form 4
| +17.47% | 35K |
—
|
—
| 235.38K |
Feb 22
| |||
Form 4
| -1.18% | -2.39K |
$31.93 | -$76,410.64 | 200.38K |
Feb 17
| |||
Form 4
| +14.06% | 25K |
—
|
—
| 202.78K |
Feb 16
| |||
Form 4
| -14.44% | -30.00K |
$50.06 | -$1,501,731.00 | 177.78K |
Scheduled
|
Jul 13
| ||
Form 4
| -8.78% | -20.00K |
$38.92 | -$778,398.75 | 207.78K |
Scheduled
|
Jul 1 - Jul 2
| ||
Form 4
| -11.64% | -30.00K |
$50.00 | -$1,500,000.00 | 227.78K |
Scheduled
|
Jun 25
| ||
Form 4
| -3.73% | -10.00K |
$40.00 | -$400,000.00 | 257.78K |
Scheduled
|
Jun 19
| ||
Form 4
| -3.60% | -10.00K |
$35.10 | -$351,038.13 | 267.78K |
Scheduled
|
Jun 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ultragenyx Pharmaceutical Inc. (RARE) Snapshot price: $55.24
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +24.14% | 19.4K |
—
|
—
| 99.77K |
Mar 1
| |||
Form 4
|
∞
| 80.37K |
—
|
—
| 80.34K |
Oct 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||